Maternal Use of Hypophyseal or Hypothalamic Hormones and Infant Congenital Malformations

  • Bengt Källén


A weak increase in malformation risk may exist after use of gonatotropin releasing hormones but this may be a result of subfertility. No teratogenic effect of drugs used at diabetes insipidus is seen but the number of exposures studied is low.


  1. Källén B, Carlsson SS, Bengtsson BKA. Diabetes insipidus and use of desmopressin (Minirin®) during pregnancy. Eur J Endocrinol. 1995;132:144–6.CrossRefGoogle Scholar
  2. Linder N, Maloth I, Ohel G, Yourish D, Tamir I. L-Deamino-8-d-arginine treatment in pregnancy and neonatal outcome. Am J Perinatol. 1986;3:165–7.CrossRefGoogle Scholar
  3. Ray JG. DDAVP use during pregnancy: an analysis on the safety for mother and child. Obstet Gynecol Surv. 1998;33:450–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Bengt Källén
    • 1
  1. 1.Tornblad Institute for Comparative EmbryologyLund UniversityLundSweden

Personalised recommendations